- Published at
- by rttnews.com
mixed
mixed
FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY
Today's Daily Dose brings you news about the progress in Flexion Therapeutics' pipeline; Immunome's coronavirus research program; Pfizer/BioNTech testing COVID-19 vaccine in pregnant women; and Rigel's deal with Lilly to develop RIPK1 inhibitors.